Perrigo Company PLC
NYSE:PRGO
Perrigo Company PLC
Operating Income
Perrigo Company PLC
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Perrigo Company PLC
NYSE:PRGO
|
Operating Income
$284.1m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-8%
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Operating Income
$659.4m
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Operating Income
-$137.8m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-11%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Operating Income
-$41.2m
|
CAGR 3-Years
-351%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Operating Income
€12.2m
|
CAGR 3-Years
61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
Ovoca Bio PLC
LSE:OVB
|
Operating Income
-€2.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
12%
|
See Also
What is Perrigo Company PLC's Operating Income?
Operating Income
284.1m
USD
Based on the financial report for Dec 31, 2023, Perrigo Company PLC's Operating Income amounts to 284.1m USD.
What is Perrigo Company PLC's Operating Income growth rate?
Operating Income CAGR 10Y
-8%
Over the last year, the Operating Income growth was 71%. The average annual Operating Income growth rates for Perrigo Company PLC have been 1% over the past three years , -10% over the past five years , and -8% over the past ten years .